| AUC |  |  | IDI |  |  |  | NRI |  |
---|
 | AUC (95% CI) | P value |  | IDI | rIDI | P value |  | NRI | P value |
---|
Model 1†| 0.65 (0.59–0.71) |  |  | Ref. | Ref. |  |  | Ref. |  |
+ ChE | 0.67 (0.60–0.73) | 0.320 |  | 0.01 | 0.36 | 0.024 |  | 0.31 | 0.010 |
Model 2‡ | 0.65 (0.60–0.71) |  |  | Ref. | Ref. |  |  | Ref. |  |
+ ChE | 0.66 (0.60–0.72) | 0.686 |  | 0.01 | 0.54 | 0.019 |  | 0.27 | 0.025 |
- ChE was each 1-SD loge-transformed. Model 1 and model 2 were predictive models established in previous studies
- †Independent variables included sex, diabetes duration, HbA1c, SBP, albuminuria, creatinine clearance, and glucose-lowering treatment
- ‡ Independent variables included age, diabetes duration, 2 h-PG, HbA1c, UCR, albuminuria, and SBP
- Abbreviations: Ref, reference; ChE, cholinesterase; DR, diabetic retinopathy; IDI, integrated discrimination improvement; rIDI, relative integrated discrimination improvement; NRI, net reclassification improvement; HbA1c, hemoglobin A1c; SBP, systolic blood pressure; 2Â h-PG, 2Â h- postprandial blood glucose; UCR, urinary creatinine